Cancer and metabolism: pathways to the future

Event date: Sun 19 Sep 2010
Location: Edinburgh

Topics at this 3 day event include metabolic transformation of cancer and targeting metabolic pathways for cancer therapies. For more details see the abcam website.

Page last updated: Fri 16 July 2010

It is supported by 12 companies:

  • Amgen
  • Astra Zeneca
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • GE Healthcare
  • GSK
  • Lilly
  • Novartis
  • Pfizer
  • Roche
  • Sanofi Aventis